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Abstract
Background: Adolescent and young adult (AYA) patients with cancer are a group with underexplored needs throughout
treatment and in survivorship. This missing knowledge can influence their quality of life (QoL). Given this fact, we have developed
a smartphone app based on a cocreation process and have an investigation of QoL among users planned as part of pilot testing
this app. Future research is warranted to determine the effect of mobile health (mHealth) tools such as smartphone apps among
the AYA cancer population.
Objective: The aim of this study was to investigate the feasibility of a smartphone app among AYA patients with cancer in
active treatment and posttreatment, in a pilot test by measuring health-related QoL before and after the use of the app.
Methods: Participants were recruited via the youth support initiative and social organization for AYAs with cancer, Kræftværket,
based at Rigshospitalet, University Hospital of Copenhagen, Denmark. Participants were evenly distributed in active treatment
and posttreatment groups. After written informed consent, all participants were asked to use the app Kræftværket as they deemed
appropriate over a 6-week period. The participants were asked to complete the 30-item European Organization for Research and
Treatment of Cancer Quality of Life Questionnaire before and after the 6-week period. The collected QoL data were analyzed
with t tests to determine differences between groups and from baseline.
Results: In total, we enrolled 20 participants, 10 in active treatment and 10 posttreatment (median time after treatment was 4
months) group. Median age of the participants was 25 years. No differences in QoL were seen at baseline (P=.65). The posttreatment
group experienced a significant increase in overall QoL after the 6-week period (global QoL: baseline 62.5, SD 22.3; after 6
weeks 80.8, SD 9.7; P=.04). For the group in active treatment, the QoL remained stable throughout the 6 weeks.
Conclusions: This study shows the feasibility and possible effect on QoL associated with the use of an mHealth tool in AYA
patients. mHealth support tools are warranted for this population.
(JMIR Mhealth Uhealth 2019;7(10):e13829)  doi: 10.2196/13829
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Introduction
Background
Adolescents and young adults (AYAs) with cancer is a patient
group with unique and often underexplored and unmet needs
throughout treatment and in survivorship [1-3]. These patients
face challenges specific to their age in physical, emotional, and
social domains, which may have a detrimental impact on their
health-related quality of life (HRQOL) [4-7]. Improving
HRQOL in AYA patients with cancer and AYA cancer survivors
is of both clinical and research interest in the disciplines of
hematology and oncology, particularly through the development
of youth-oriented interventions [8].
Smartphone apps and other mobile health (mHealth)
interventions have been increasingly used for AYAs with cancer,
as well as for AYAs with other acute or chronic disease [9-11].
Apps are attractive tools for AYA oncology and hematology
interventions because of their inherent capability of fulfilling a
wide number of tasks, including social networking, health
tracking, health promotion, and information provision [12,13].
In addition, they are particularly useful for AYA patients, who
are often technologically savvy and high users of smartphone
technology [13,14]. However, there has been criticism regarding
the design of these smartphone apps, based upon limited youth
input in design and incomplete or inadequate evaluation of these
apps [9,10,15,16].
Despite these limitations, smartphone apps and other mHealth
interventions still demonstrate potential to serve as useful
interventions for AYAs with cancer and AYA cancer survivors.
On the basis of a cocreation process, our research team at
Rigshospitalet, University Hospital of Copenhagen, Denmark,
has developed a smartphone app, Kræftværket, to improve the
QoL in AYAs with cancer and AYA cancer survivors [17,18].
The Kræftværket app, which is named after a youth support
initiative and social organization for AYAs with cancer out of
Rigshospitalet with the same name, has been designed with 3
primary features: (1) a symptom and activity diary, (2) a
communication network between app users, and (3) an
information database including video content. All features were
selected and refined using the process of cocreation, in which
AYA input was used to determine app content and design. The
evaluation protocol for this app has been designed according
to 2 evaluation stages: pilot testing and implementation testing
[19]. The pilot testing consists of a qualitative and quantitative
launch of the app to a small group of 20 AYA patients with
cancer and cancer survivors, with quantitative evaluation using
the 30-item European Organization for Research and Treatment
of Cancer Quality of Life Questionnaire (EORTC QLQ-C30)
instrument, and qualitative evaluation using focus group
interviews and think-aloud testing [19]. Results of pilot testing
will be used to modify and improve the app for launch of the
app to a larger number of participants for implementation
testing.
Objectives
The aim of this study was to present the quantitative HRQOL
data from the Kræftværket app pilot testing.
Methods
Overview
Detailed methods on the Kræftværket app development project
are described in 2 separate papers [17,19]. As mentioned
previously, the Kræftværket app was designed with 3 primary
features: (1) a symptom and activity diary, (2) a communication
network between app users, and (3) an information database
including video content. The communication network allowed
for nonmediated group-based communication between users as
requested by the users during the cocreation process. The study
plan was to evaluate the feasibility of the use of the Kræftværket
app while measuring QoL in a pre-post study design.
Participants and Recruitment
Kræftværket is a youth support initiative and social organization
for AYA patients with cancer aged 15 to 29 years based at
Rigshospitalet University Hospital of Copenhagen, Denmark
[17]. Inclusion criteria for app pilot testing were AYAs aged
15 to 29 years with prior Kræftværket initiative contact and
access to a smartphone and the internet, including cellular data
or Wi-Fi. Participants were excluded if they were unable to read
and write in Danish, and if they participated in the cocreation
activities that determined app content and design [19]. For the
pilot-testing phase, 20 previous or current Kræftværket users
were recruited to pilot-test the app and provide qualitative and
quantitative feedback. Recruitment was targeted to obtain 10
participants currently undergoing treatment for cancer, and 10
participants who had completed treatment for cancer.
Participants were invited to participate in the study through
invitation in the open Facebook group Kræftværket
Rigshospitalet or while participating in other Kræftværket
initiatives at Rigshospitalet. No individual patient was
approached. The demographic data were provided by the AYAs
themselves.
Pilot Testing
After obtaining informed consent, participants provided baseline
measurements of HRQOL using the validated EORTC QLQ-C30
instrument for overall and subdomain QoL measurement. No
other EORTC modules or instruments were used throughout
this pilot testing.
Participants were asked to download the Kræftværket app and
contact the software developer, Daman, to obtain a log-in,
followed by using the Kræftværket app over the course of 6
weeks. Upon completing written informed consent, participants
were shown the app and the 3 features by youth coordinator
MH, but they were not given any specific instructions on
suggested frequency of app use; instead, they were asked to use
the app as they deemed fit. At the end of the 6-week period,
they were asked to complete a secondary EORTC QLQ-C30.
The original protocol for app evaluation stated that participants
would be prompted to complete the EORTC QLQ-C30 via the
app; however, this instrument was completed in paper form
because of changes in personal data protection rules.
At this time, additional qualitative data were collected by author
SH in the form of semistructured focus group interviews and
individual think-aloud tests. The qualitative data were collected
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after the completion of the QLQ-C30 after the 6-week period.
Data from the qualitative aspects of this pilot test will be
published in 2 separate papers [20,21].
Statistical Analysis
Statistical analysis was performed with IBM SPSS version 25.0.
Descriptive statistics and frequencies were used to display
sociodemographic and clinical data. A paired t test was
performed to determine differences in global QoL from baseline.
Differences over time are illustrated by a boxplot. No statistical
analyses were performed between groups as the sample size did
not allow for between-group comparisons.
Ethical Considerations
We obtained informed consent from all individual participants
included in the study, whereas caregiver informed consent was
given for patients younger than 18 years. All procedures
performed in studies involving human participants were in
accordance with the ethical standards of the institutional and
national research committee and with the 1964 Helsinki
declaration and its later amendments or comparable ethical
standards. This research was exempt from review by an
institutional review board or ethical authority under Danish law.
Due to the Danish Data Protection law restrictions, the tracking
data registered through the app of the patients participating in
this study were not available. Permission to conduct the study
was granted by the Data Protection Agency (j.nb. 2012-58-0004,
i-suite nb.:6217).
Results
Participants and Recruitment
Over a 2-week period, 21 patients were approached at
Kræftværket; of these, only 1 patient declined participation. In
total, 20 recruited patients, 10 in active treatment and 10
posttreatment, completed written informed consent. Of these
participants, 70% (14/20) were female. Among the participants
in the active treatment group, the gender distribution was 60%
(6/10) vs 40% (4/10) with a majority of females. This dispersion
increased in the posttreatment group with 80% (8/10) women.
Median age of the participants was 25 years, and for the
posttreatment group, the median time elapsed from diagnosis
to start of study was 4 months. The type of cancer was
predominantly hematologic cancer (50%, 10/20) followed by
breast cancer (20%, 4/20). Table 1 presents the demographic
and clinical data.
Pilot Testing
The mean global QoL at baseline was similar in the 2 treatment
groups (active treatment group 66.67 vs posttreatment group:
62.5, P=.65); see boxplot in Figure 1. Table 2 shows the average
EORTC QLQ-C30 domain scores. All domains are scored on
a 0 to 100 scale. Although a higher global QoL score indicates
better QoL, the symptom scales, for example, pain and nausea,
are reversely scored, with a higher score indicating more
impairment. These scores reveal a difference in baseline scores
in favor of the posttreatment group for the subdomains role
functioning, emotional functioning, cognitive functioning, and
social functioning, and the single items for fatigue, nausea,
dyspnea, insomnia, appetite loss, and financial difficulties. On
the contrary, the single items on pain, constipation, and diarrhea
were higher at baseline in the posttreatment group. Due to the
large disparity between diagnoses and treatments received, no
statistical analyses were performed for these data. A significant
increase in global QoL was found for the posttreatment group
from baseline to 6 weeks (difference estimate 18.3; 95% CI
1.5-35.1; P=.04). The paired analysis found no difference from
baseline to 6 weeks after the use of the app for the group in
active treatment (difference estimate 1.7; 95% CI –5.6 to 9.0;
P=.61).
Table 1. Demographic and clinical information of participants (N=20).
Posttreatment group (n=10)Active treatment group (n=10)All participants (N=20)Clinical data
Gender, n (%)
2 (20)4 (40)6 (30)Male
8 (80)6 (60)14 (70)Female
28 (16-29)24 (19-29)25 (16-29)Age (years), mean (range)
Cancer type, n (%)
4 (44)5 (56)9 (45)Lymphoma
1 (25)3 (75)4 (20)Breast
1 (50)1 (50)2 (10)Head and neck
1 (100)0 (0)1 (5)Leukemia
1 (100)0 (0)1 (5)Testicular
1 (100)0 (0)1 (5)Ventricular
0 (0)1 (100)1 (5)Thyroid
1 (100)0 (0)1 (5)Brain
4 (1-41)—
—
aMedian time posttreatment, months (range)
aNot applicable.
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Figure 1. Boxplot of difference in baseline and 6-week global quality of life scores.
Table 2. Mean value for the 30-item European Organization for Research and Treatment of Cancer Quality of Life Questionnaire scales at baseline
and 6-week measurement.
Posttreatment, mean (SD)Active treatment, mean (SD)EORTC QLQ-C30a domains
6 weeksBaseline6 weeksBaseline
80.83 (9.66)62.5 (22.31)68.33 (17.48)66.67 (17.12)Global health status/quality
of life
87.33 (15.85)80.67 (15.85)77.33 (30.66)74.67 (30.27)Physical functioning
81.67 (32.82)68.33 (30.88)60 (27.44)55 (32.44)Role functioning
82.67 (12.25)68.67 (28.47)63.33 (21.59)65.83 (27.34)Emotional functioning
86.67 (17.21)63.33 (33.15)71.67 (33.38)55 (36.89)Cognitive functioning
81.67 (21.44)78.33 (30.48)75 (25.15)73.33 (30.63)Social functioning
33.33 (13.86)42.22 (22.71)44.44 (23.42)50 (21.11)Fatigue
11.67 (13.72)10 (11.65)23.33 (31.62)20 (31.23)Nausea
13 (15.32)33.33 (34.25)25 (30.68)22 (23.64)Pain
6.67 (14.05)16.67 (17.57)23.33 (31.62)33.33 (27.22)Dyspnea
30 (29.19)30 (33.15)36.67 (39.91)50 (28.33)Insomnia
6.67 (14.05)10 (16.10)26.67 (37.84)30 (36.68)Appetite loss
16.67 (23.57)16.67 (32.39)13.33 (32.20)6.67 (14.05)Constipation
6.67 (14.05)13.33 (23.31)13.33 (32.20)10 (22.50)Diarrhea
3.33 (10.54)13.33 (23.31)50 (39.28)50 (39.28)Financial difficulties
aEORTC QLQ-C30: 30-item European Organization for Research and Treatment of Cancer Quality of Life Questionnaire.
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Discussion
Principal Findings
This study has demonstrated feasibility and possible impact of
a smartphone app on the HRQOL in this small AYA population.
Our results show that QoL may be positively affected in a group
of patients posttreatment after a short period of use of a
specifically designed mHealth tool.
The field of mHealth technologies designed for individuals with
cancer is in a period of rapid growth and development. The
present smartphone app may fill the gap for a population in
need of added support. Other mHealth tools may have the same
potential but have until now lacked testing and validation in an
appropriate population [9,10,15]. Several studies have affirmed
the feasibility of mHealth use in different populations, thus
creating opportunities for similar strategies in other cancer
populations, such as older adults, in both active treatment and
survivorship, as well as AYA with other conditions.
The increase seen in QoL may be explained by several factors.
Posttreatment patients not in daily contact with fellow patients
or hospital personnel may experience improvement in QoL
using the Kræftværket app owing to added social interaction
and increased sense of belonging. A study by Kaal et al
introduces the relationship between empowerment and HRQOL
in AYA patients and demonstrates that empowerment is
positively associated with HRQOL [22]. Empowerment has
previously been theorized as a broad construct of intrapersonal,
interactional, and behavioral components [23]. When extending
these constructs to our data, the interactional component (eg,
the social interaction feature of the app) may be able to explain
the development seen, although, in this study, we do not have
data on which of the 3 individual elements of the app were used
most frequently by participants. Thus, we cannot be sure if the
increase in QoL is a result of increased empowerment through
an element of social interaction. Patients still in active treatment
have regular contact with their health care provider, and, in our
case, the Kræftværket group and associated personnel. As such,
they may not experience an added sense of belonging through
using an interactive app such as Kræftværket. This may be an
explanation for this group of participants not experiencing the
same benefits as the posttreatment group. However, for some
AYA populations, for example, AYAs with hematological
cancers going through burdensome treatments, one may expect
a decrease in QoL. In this study, 50% of the AYAs in active
treatment were treated for hematological cancer, yet no decrease
in QoL was seen for this group. Due to the study design, the
course of QoL for patients not exposed to the app cannot be
reported. This can only be explored in a randomized trial design.
However, literature informs us of the many issues presumed to
affect the QoL of these patients after treatment. Therefore, one
would expect a decrease in QoL after treatment [24]. This
decrease is not seen in this study, thus emphasizing the possible
effect of the Kræftværket app.
The levels of global QoL recorded at baseline by EORTC
QLQ-C30 are comparable with previous published data for
posttreatment AYA patients [25,26], although lower than the
levels in an adult cancer population [27]. The difference in age
compared with the adult cancer populations may have an impact
on QoL because younger people in important developmental
phases of life have higher expectations to life and, thus, a worse
experience of the misfortunes of life [28]. In addition, an
explanation for the lower overall QoL could be the dominant
group of hematologic cancer patients in this and similar AYA
studies [25,26]. These patients go through a longer and by many
accounts more demanding oncological treatment. Interestingly,
the 6-week global QoL value for the posttreatment group in this
study was comparable with an age-standardized group of
German citizens without cancer as shown by Geue et al [25],
thus demonstrating a potential for the Kræftværket app in this
population.
Given the potential of the current app, and similar apps for an
AYA population in need of added support, the access to
smartphone technology is a requirement. A review from 2015
indicates a concern for individuals of lower sociodemographic
status and restricted access to smartphones as high as 25% [10].
Restricted access would undoubtedly create a selection bias of
whom would benefit from this technology. However, several
surveys performed in 2015-2018 from comparable countries
have shown very high access to smartphone for the age group
of 12 to 34 years (89%-98%) [14,29,30].
Strengths of this study include the feasibility testing of a
smartphone app for patients with cancer including the possible
positive effects its use has on these patients. Moreover, this app
has been tested in a diverse AYA population with a large variety
of cancer diseases represented. In addition, the app is tested in
2 different settings, during active treatment and posttreatment,
thus implying its use in a survivorship setting for the potential
benefit of a large population. Finally, the cocreation process
during the development of this app and during the process of
this study with direct patient involvement (coauthor MJ) may
certainly have a role in the success of its use, hence encouraging
a similar process in the development of future apps [19].
Some limitations do need to be addressed. First, the pre-post
study design in a very small population clearly represents a
limitation and lessens the possible interpretations of the
presented data. In addition, owing to the data protection
restrictions in Denmark, the tracking information of app use
was not available to report. Therefore, we do not know how and
to what extent the participants used the app, thereby rendering
it difficult to conclude why the posttreatment group experienced
an increase in QoL, which may have been seen even without
the use of the app. In addition, because the clinical information
of cancer disease was self-reported by the patients, we did not
have data on the stage of disease or specific oncological
treatment. These data may have contributed to a more thorough
explanation of the observed lower global QoL scores in these
participants, as patients at the end of their lives would expect
to experience a decrease in QoL [22]. Finally, although the
EORTC QLQ-C30 has been used in more than a thousand
clinical trials and daily clinics, several groups have allegated
that this instrument is noncomprehensive and does not cover
all the QoL aspects important to AYAs [4-6]. In previous studies
by Nightingale et al and Quinn et al, 3 constructs were described
as lacking for the AYA population: perceived sense of self,
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relationships, and parenthood [31,32]. Therefore, the QoL results
may not portray the complete picture of these patients’ QoL.
Perspectives
This study shows the feasibility and possible positive effects
on QoL by use of an mHealth tool in AYA patients. The study
gives hope to the use of mHealth tools to improve QoL in AYAs
with cancer. Future studies evaluating the impact of the
Kræftværket app in the AYA cancer population will show the
effect implementation of mHealth tools may have on this patient
group.
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